COVID-19 vaccine update ICYMI - US' Novavax doubles its manufacturing capability

Author: Eamonn Sheridan | Category: News

Novavax had a deal in place with Serum Institute of India for 1bn doses / year.

  • Its now agreed with the lab firm for 2 bn doses / year.
When a vaccine is approved, of course.
production will be for low- and middle-income countries and India.
By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookiesClose